1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, January 2016 (p9)

Biological Therapy Analysis & Statistics, January 2016 (p9)

24/7 Customer Support

Talk to Veronica

+44 207 0971 241

241-270 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Interferon Receptor Binders -Pipeline Insights, 2016

Interferon Receptor Binders -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon Receptor Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon Recepto ...

  • Industries : Biological Therapy
Interleukin (IL) Inhibitors -Pipeline Insights, 2016

Interleukin (IL) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) ...

  • Industries : Biological Therapy
Integrase Inhibitors -Pipeline Insights, 2016

Integrase Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Integrase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Integrase Inhibitors. The ...

  • Industries : Biological Therapy
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2016

Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2016

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatocyte ...

  • Industries : Biological Therapy
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2016

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon ...

  • Industries : Biological Therapy
 Growth Hormone Deficiency-Pipeline Insights, 2016

Growth Hormone Deficiency-Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. ...

  • Industries : Biological Therapy, Biopharmaceutical
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hematopoietic ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
Plerixafor  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Plerixafor - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • € 1 120
  • Industry report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Biological Therapy
Global Gene Therapy Market Forecast to 2020

Global Gene Therapy Market Forecast to 2020

  • € 1 760
  • Industry report
  • January 2016
  • by RNCOS

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches ...

  • Industries : Biological Therapy, Drug Delivery
  • Countries : World
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2016

Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
GM-CSF Inhibitors -Pipeline Insights, 2016

GM-CSF Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “GM-CSF Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the GM-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016

  • € 1 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
Global Therapeutic Vaccines Market Growth, Trends & Forecast 2015 - 2020

Global Therapeutic Vaccines Market Growth, Trends & Forecast 2015 - 2020

  • € 3 400
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The Global market for Therapeutic vaccines is expected to reach US$4.82 billion by the end of 2020 growing at a CAGR of around 33.6% from 2015 to 2020. Several new approaches are being developed in orde ...

  • Industries : Therapy, Biopharmaceutical, Pathology, Biotechnology, Biological Therapy
  • Countries : World
Neuralstem, Inc. (USA)

Neuralstem, Inc. (USA)

  • € 880
  • Company report
  • January 2016
  • by Global Industry Analysts

This report presents quick facts about Neuralstem, Inc., which is principally involved in the Development and Commercialization of Regenerative Medicine Treatments. Illustrated with 22 tables, the report ...

  • Countries : United States
MultiVir, Inc. (USA)

MultiVir, Inc. (USA)

  • € 240
  • Company report
  • January 2016
  • by Global Industry Analysts

This report presents quick facts about MultiVir, Inc., which is principally a Clinical-Stage Gene Therapy Company. Illustrated with 6 tables, the report showcases the company's key markets and market position ...

  • Countries : United States
StemCells, Inc. (USA)

StemCells, Inc. (USA)

  • € 1 320
  • Company report
  • January 2016
  • by Global Industry Analysts

This report presents quick facts about StemCells, Inc., which is principally involved in Stem Cell Therapeutics Business. Illustrated with 33 tables, the report showcases the company's recent news stories ...

  • Countries : United States
Stem Cells Pipeline Highlights – 2016

Stem Cells Pipeline Highlights – 2016

  • € 544
  • Industry report
  • January 2016
  • by Fore Pharma

The latest report Stem Cells Pipeline Highlights – 2016, provides most up-to-date information on key pipeline molecules in the global Stem Cells market. It covers emerging therapies for Stem Cells in ...

  • Industries : Biological Therapy
HIV / AIDS - Pipeline Review, H2 2015

HIV / AIDS - Pipeline Review, H2 2015

  • € 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

HIV / AIDS - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H2 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline. This report provides ...

  • Industries : Therapy, Pharmaceutical, Biotechnology, Biopharmaceutical, Research and Development
  • Countries : United States
Melanoma - Pipeline Review, H2 2015

Melanoma - Pipeline Review, H2 2015

  • € 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Melanoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Melanoma - Pipeline Review, H2 2015’, provides an overview of the Melanoma’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Head And Neck Cancer - Pipeline Review, H2 2015

Head And Neck Cancer - Pipeline Review, H2 2015

  • € 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Head And Neck Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H2 2015’, provides an overview of the Head And Neck Cancer’s therapeutic ...

  • Industries : Healthcare, General Medicine and Specialty Medicine
  • Countries : United States
Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2015

Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2015

  • € 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2015’, provides an overview of the Multiple ...

  • Industries : Cancer, Pathology
  • Countries : United States
Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015

  • € 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

  • € 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Glioblastoma Multiforme ...

  • Industries : Cancer, Pathology
  • Countries : United States
About 3 200 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • June 2016
    20 pages
  • Antisense  

    Antisense RNA  

    Antisense Techn...  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.